StonvexLoading…
StonvexStonvexStonvexCore line items from DHC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $366.47M | $1.54B | $1.16B | $769.58M |
Operating Income | $-42.75M | $-320.90M | $-273.09M | $-104.30M |
Net Income | $-43.27M | $-285.89M | $-264.67M | $-91.64M |
EPS (Diluted) | $-0.18 | $-1.19 | $-1.10 | $-0.42 |
Total Assets | $4.27B | $4.36B | $4.68B | $4.76B |
Total Liabilities | $2.65B | $2.70B | $3.00B | $2.90B |
Cash & Equivalents | $121.77M | $105.41M | $201.37M | $141.77M |
Free Cash Flow OCF − CapEx | $-26.82M | $-166.44M | $-113.90M | $-24.05M |
Shares Outstanding | 242.11M | 242.12M | 242.15M | 241.42M |